Brains Technology, Inc.
Brains Technology, Inc. Fundamental Analysis
Brains Technology, Inc. (4075.T) shows weak financial fundamentals with a PE ratio of 58.75, profit margin of 12.24%, and ROE of 10.15%. The company generates $1.3B in annual revenue with weak year-over-year growth of -4.67%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 44.7/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 4075.T's fundamental strength across five key dimensions:
Efficiency Score
Weak4075.T struggles to generate sufficient returns from assets.
Valuation Score
Weak4075.T trades at a premium to fair value.
Growth Score
Weak4075.T faces weak or negative growth trends.
Financial Health Score
Excellent4075.T maintains a strong and stable balance sheet.
Profitability Score
Weak4075.T struggles to sustain strong margins.
Key Financial Metrics
Is 4075.T Expensive or Cheap?
P/E Ratio
4075.T trades at 58.75 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 4075.T's PEG of 2.92 indicates potential overvaluation.
Price to Book
The market values Brains Technology, Inc. at 5.77 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 25.92 times EBITDA. This signals the market has high growth expectations.
How Well Does 4075.T Make Money?
Net Profit Margin
For every $100 in sales, Brains Technology, Inc. keeps $12.24 as profit after all expenses.
Operating Margin
Core operations generate 15.38 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.15 in profit for every $100 of shareholder equity.
ROA
Brains Technology, Inc. generates $8.09 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Brains Technology, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Brains Technology, Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
4075.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
58.75
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
2.92
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.77
vs 25 benchmark
P/S Ratio
Price to sales ratio
7.19
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
5.70
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.10
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How 4075.T Stacks Against Its Sector Peers
| Metric | 4075.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 58.75 | 34.43 | Worse (Expensive) |
| ROE | 10.15% | 1135.00% | Weak |
| Net Margin | 12.24% | -134663.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 5.70 | 5.77 | Strong Liquidity |
| ROA | 8.09% | -310462.00% (disorted) | Weak |
4075.T outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Brains Technology, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
110.37%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
10.37%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
117.36%
Industry Style: Growth, Innovation, High Beta
High Growth